Tobramycin for Horses: Uses, Dosing & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Tobramycin is an aminoglycoside antibiotic. In horses, it is used most often as an ophthalmic medication rather than a routine whole-body antibiotic. Your vet may prescribe it as a 0.3% eye drop or ointment for bacterial infections on the surface of the eye, especially when a corneal ulcer or severe conjunctival infection is present.

This drug is valued because aminoglycosides have activity against many aerobic bacteria, including organisms that can be aggressive in equine eye disease. In practice, vets often think about tobramycin when they are concerned about gram-negative bacteria such as Pseudomonas, which can rapidly worsen a corneal ulcer.

In horses, tobramycin is usually an extra-label medication, meaning your vet is using a human or small-animal product in a medically appropriate way for an equine patient. That is common in equine ophthalmology. The exact plan depends on the ulcer depth, culture results, pain level, and whether your horse can safely tolerate frequent eye treatment.

The most common use of tobramycin in horses is bacterial eye infection treatment. Your vet may use it for corneal ulcers, bacterial keratitis, conjunctivitis, or infected eye wounds. It is especially useful when the infection may involve gram-negative bacteria or when culture and sensitivity testing shows the bacteria should respond to tobramycin.

Tobramycin is not a good fit for every eye problem. Many painful equine eye conditions are not primarily bacterial, and some ulcers are fungal, immune-mediated, traumatic, or mixed infections. Because horses are also prone to keratomycosis after corneal injury, your vet may pair or replace antibiotics with antifungal treatment depending on exam findings.

In severe or complicated ulcers, tobramycin is often only one part of a larger plan. Your vet may also recommend atropine for pain control, anti-inflammatory medication, serum or other anti-collagenase therapy for melting ulcers, a subpalpebral lavage system for frequent dosing, or referral for surgery if the cornea is deep or unstable.

Tobramycin dosing in horses depends heavily on where the infection is, how severe it is, and whether culture results are available. For most equine patients, the medication is used topically in the eye as a 0.3% solution or ointment. In uncomplicated cases, your vet may prescribe it every 4 to 6 hours. In more serious corneal ulcers, especially early in treatment, dosing may be needed every 1 to 2 hours, then tapered as the eye improves.

Equine ophthalmology references also describe subconjunctival administration by a veterinarian in selected cases, and older AAEP guidance lists topical or subconjunctival use intervals ranging from about every 2 to 8 hours depending on the formulation and severity. Because horses often resist frequent eye medication, your vet may recommend a subpalpebral lavage system so treatment can be given safely and consistently.

Systemic aminoglycoside dosing information is sometimes discussed in pharmacology references, but injectable aminoglycosides in horses are usually gentamicin or amikacin rather than tobramycin. If your vet ever considers systemic aminoglycoside therapy, kidney monitoring becomes much more important. Never reuse leftover eye medication or change the schedule on your own. Missing doses can slow healing, but overusing antibiotics can also increase irritation and resistance concerns.

With topical ophthalmic use, the most common side effects are local and fairly mild: stinging, redness, swelling, tearing, or temporary irritation right after the medication is applied. Some horses also resent the drops because the eye is already painful. If your horse becomes much more squinty, rubs the eye harder, or the discharge suddenly worsens, contact your vet.

A true allergic or hypersensitivity reaction is uncommon but possible. If the eyelids become markedly swollen, the conjunctiva looks much redder, or the eye seems worse instead of better after starting treatment, your vet may want to recheck the eye and consider a different medication.

The more serious aminoglycoside risks are kidney injury and neuromuscular effects, but these are mainly concerns with systemic use, not routine eye drops. Horses at higher risk for aminoglycoside kidney problems include foals, older horses, dehydrated horses, and horses with existing kidney compromise or sepsis. If your horse is on multiple medications or is hospitalized for a severe infection, your vet may recommend bloodwork and hydration monitoring.

For topical eye use, major drug interactions are limited, and veterinary references note that no well-established ophthalmic interactions are commonly reported. Even so, your vet still needs a full medication list. Eye medications can interfere with each other if they are applied too close together, and contaminated bottles can worsen infection.

If your horse is receiving systemic aminoglycosides or other potentially kidney-stressing drugs, interaction risk matters more. Aminoglycosides can be harder on the kidneys when combined with other nephrotoxic medications, including amphotericin B and furosemide. Merck also notes that aminoglycosides can have neuromuscular blocking effects, so caution is warranted in horses with weakness or when other drugs affecting neuromuscular function are being used.

If your horse is on several eye medications, ask your vet what order to give them in and how long to wait between products. In many cases, drops are spaced by several minutes, and ointments are applied last. That small detail can make treatment work better.